What HERBORIUM's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Gilligan James P | Director | Oct 06 | Open-market buy · P | −605,769 | $0.01 | −$7.87K | 41,952,527 |
| Olszewksi Agnes P | CEO/CSO/CHAIRMAN | Oct 06 | Open-market buy · P | −605,769 | $0.01 | −$7.87K | 43,689,600 |
| Lee Hui | Senior Vice President | Dec 30 | Open-market sale · S | −4,300,000 | $0.77 | −$3.31M | 0 |
| Li Theodore S | CFO, COO | Dec 30 | Open-market sale · S | −2,154,300 | $0.77 | −$1.66M | 0 |
Loading...
